Some dosage strengths of both Victoza and Saxenda are included on the FDA's shortages list, mainly due to pressures on Novo Nordisk's production capacity for its entire GLP-1 franchise, but the company insists that this does not satisfy the requirements for compounding
Clinical trials have shown that it can help participants lose a substantial amount of weight when combined with diet and exercise, making it a viable option for those who have struggled with other methods
Subgroup analyses included follow-up duration, comparator type, and baseline condition
"First we destroy the wings, then we engage the biceps
S-Acetyl L-Glutathione is a dietary supplement containing a form of glutathione that, according to preclinical research, is more stable in the blood and increases glutathione levels within cells better than non-acetylated glutathione